These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30799793)

  • 1. Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α.
    Doebelin C; He Y; Campbell S; Nuhant P; Kumar N; Koenig M; Garcia-Ordonez R; Chang MR; Roush WR; Lin L; Kahn S; Cameron MD; Griffin PR; Solt LA; Kamenecka TM
    Med Chem; 2019; 15(6):676-684. PubMed ID: 30799793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.
    Kumar N; Solt LA; Conkright JJ; Wang Y; Istrate MA; Busby SA; Garcia-Ordonez RD; Burris TP; Griffin PR
    Mol Pharmacol; 2010 Feb; 77(2):228-36. PubMed ID: 19887649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.
    Wang Y; Kumar N; Nuhant P; Cameron MD; Istrate MA; Roush WR; Griffin PR; Burris TP
    ACS Chem Biol; 2010 Nov; 5(11):1029-34. PubMed ID: 20735016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist.
    Kumar N; Kojetin DJ; Solt LA; Kumar KG; Nuhant P; Duckett DR; Cameron MD; Butler AA; Roush WR; Griffin PR; Burris TP
    ACS Chem Biol; 2011 Mar; 6(3):218-22. PubMed ID: 21090593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol).
    Wang Y; Kumar N; Crumbley C; Griffin PR; Burris TP
    Biochim Biophys Acta; 2010 Aug; 1801(8):917-23. PubMed ID: 20211758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of biaryls as RORγ inverse agonists by using structure-based design.
    Enyedy IJ; Powell NA; Caravella J; van Vloten K; Chao J; Banerjee D; Marcotte D; Silvian L; McKenzie A; Hong VS; Fontenot JD
    Bioorg Med Chem Lett; 2016 May; 26(10):2459-2463. PubMed ID: 27080181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist.
    Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H
    J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LXR-mediated inhibition of CD4+ T helper cells.
    Solt LA; Kamenecka TM; Burris TP
    PLoS One; 2012; 7(9):e46615. PubMed ID: 23029557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases.
    Sun N; Ma X; Zhou K; Zhu C; Cao Z; Wang Y; Xu J; Fu W
    Eur J Med Chem; 2020 Feb; 187():111984. PubMed ID: 31881455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc.
    Fauber BP; de Leon Boenig G; Burton B; Eidenschenk C; Everett C; Gobbi A; Hymowitz SG; Johnson AR; Liimatta M; Lockey P; Norman M; Ouyang W; René O; Wong H
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6604-9. PubMed ID: 24239186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.
    Kojima H; Muromoto R; Takahashi M; Takeuchi S; Takeda Y; Jetten AM; Matsuda T
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):338-45. PubMed ID: 22289359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis.
    Ouvry G; Atrux-Tallau N; Bihl F; Bondu A; Bouix-Peter C; Carlavan I; Christin O; Cuadrado MJ; Defoin-Platel C; Deret S; Duvert D; Feret C; Forissier M; Fournier JF; Froude D; Hacini-Rachinel F; Harris CS; Hervouet C; Huguet H; Lafitte G; Luzy AP; Musicki B; Orfila D; Ozello B; Pascau C; Pascau J; Parnet V; Peluchon G; Pierre R; Piwnica D; Raffin C; Rossio P; Spiesse D; Taquet N; Thoreau E; Vatinel R; Vial E; Hennequin LF
    ChemMedChem; 2018 Feb; 13(4):321-337. PubMed ID: 29327456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.
    Slominski AT; Kim TK; Hobrath JV; Oak ASW; Tang EKY; Tieu EW; Li W; Tuckey RC; Jetten AM
    J Steroid Biochem Mol Biol; 2017 Oct; 173():42-56. PubMed ID: 27693422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes.
    Solt LA; Banerjee S; Campbell S; Kamenecka TM; Burris TP
    Endocrinology; 2015 Mar; 156(3):869-81. PubMed ID: 25560829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors.
    Toyama H; Nakamura M; Nakamura M; Matsumoto Y; Nakagomi M; Hashimoto Y
    Bioorg Med Chem; 2014 Mar; 22(6):1948-59. PubMed ID: 24559867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes.
    Jetten AM; Kurebayashi S; Ueda E
    Prog Nucleic Acid Res Mol Biol; 2001; 69():205-47. PubMed ID: 11550795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reversed sulfonamide series of selective RORc inverse agonists.
    van Niel MB; Fauber BP; Cartwright M; Gaines S; Killen JC; René O; Ward SI; de Leon Boenig G; Deng Y; Eidenschenk C; Everett C; Gancia E; Ganguli A; Gobbi A; Hawkins J; Johnson AR; Kiefer JR; La H; Lockey P; Norman M; Ouyang W; Qin A; Wakes N; Waszkowycz B; Wong H
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5769-5776. PubMed ID: 25453817
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.